Dalton Medicinal Chemistry will apply their proprietary insights to the design and synthesis of new classes of compounds against selected Riboswitch targets. BioRelix will advance these compounds with
“As CDEX overcame the scientific hurdles associated with our product lines, two years ago we agreed that I would transition to a support role for the company allowing
Daiichi Sankyo brought patent infringement actions in Tokyo District Court against seven generics companies: Shiono Chemical Co, Taiyo Yakuhin Co, Takata Seiyaku Co, Nichi-Iko Pharmaceutical Co, Nihon Generic
In the US several patients with cancer have now been treated with the company’s survivin inhibitor, which is jointly developed by Santaris Pharma and Enzon Pharmaceuticals. The FDA
ImVisioN Therapeutics, a biopharmaceutical company, has obtained positive Phase I clinical results for its lead product, IVN201, an immunotherapeutic product for the treatment of cat dander allergy. The
Mr McKee is the executive vice president and CFO of Barr Pharmaceuticals, a subsidiary of Teva Pharmaceutical Industries. Prior to joining Barr, Mr McKee served as director of
The company has signed a lease for a 40,405 square foot building in Austin, Texas, that was previously used by Sorin Carbomedics. On-X Life will begin a 19-month
The approval of Lexapro for the treatment of adolescent depression was supported by two placebo-controlled studies, one conducted in adolescent patients taking Lexapro and one conducted in children
Navigenics, a genomics testing company, has acquired the Affymetrix clinical services laboratory, a CLIA-certified testing facility that provides molecular genome scanning using the Affymetrix GeneChip microarray platform. With
Roche has reported positive results from ToGA, an international Phase III trial investigating the benefit of Herceptin as the first therapy for patients with advanced and inoperable stomach
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.